Showing results (461-470 of 512) with videos related to

Sort By:
Pageof 52
The Lancet. Gastroenterology & Hepatology|April 19, 2024
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort studyNeil Chanchlani, Simeng Lin, Claire Bewshea, et al.
Frontline Gastroenterology|July 27, 2018
Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Jonathan Digby-Bell, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 TrialMarc Ferrante, Peter M Irving, Maria T Abreu, et al.
Drugs|June 4, 2020
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory DiseasesHoUng Kim, Rieke Alten, Luisa Avedano, et al.
Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.
Gastrohep|December 28, 2020
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centreEsha Sharma, Susanna Meade, Francesca D'Errico, et al.
Drugs|February 1, 2020
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory DiseasesHoUng Kim, Rieke Alten, Luisa Avedano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Cell|September 20, 2016
Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell CompartmentsRafael Di Marco Barros, Natalie A Roberts, Robin J Dart, et al.
Scandinavian Journal of Gastroenterology|October 2, 2018
Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective studyJonathan P Segal, Lawrence Penez, Soad Mohsen Elkady, et al.
Pageof 52